ELYSIUM THERAPEUTICS INC has a total of 20 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals are DENG XUEFENG, LEOPOLDO ESPINOSA ABDALA and SINGH NIKHILESH N.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | United Kingdom | 2 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Jenkins Thomas E | 18 |
#2 | Husfeld Craig O | 5 |
#3 | Thomas E Jenkins | 2 |
Publication | Filing date | Title |
---|---|---|
AU2018234911A1 | Polysubunit opioid prodrugs resistant to overdose and abuse | |
US2018085366A1 | Opioid compositions resistant to overdose and abuse | |
GB201804135D0 | Polysubunit opioid prodrugs resistant to overdose and abuse | |
WO2016064914A1 | Diversion-resistant opioid formulations |